Tianeptine, first developed as a mood-boosting compound in France , has sparked considerable controversy globally . Unlike typical antidepressants which work by increasing serotonin levels, tianeptine seems to enhance mood transport and impacts brain chemistry, leading unique responses. Its accessibility on the copyright, often bypassing regulatory